Biblio
Export 1381 results:
Author Title Type [ Year
Filters: First Letter Of Last Name is G [Clear All Filters]
“Primary cortical cell tri-culture to study effects of amyloid-β on microglia function and neuroinflammatory response.”, J Alzheimers Dis, vol. 102, no. 3, pp. 730-741, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “Recent Advances in Drug Delivery Systems Targeting Insulin Signalling for the Treatment of Alzheimer's Disease.”, J Alzheimers Dis, vol. 98, no. 4, pp. 1169-1179, 2024.
, “RNA Analysis of Circulating Leukocytes in Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 4, pp. 1673-1683, 2024.
, “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
, “Sildenafil as a Candidate Drug for Alzheimer's Disease: Real-World Patient Data Observation and Mechanistic Observations from Patient-Induced Pluripotent Stem Cell-Derived Neurons.”, J Alzheimers Dis, vol. 98, no. 2, pp. 643-657, 2024.
, “Substantial Doubt Remains about the Efficacy of Anti-Amyloid Antibodies.”, J Alzheimers Dis, vol. 97, no. 2, pp. 567-572, 2024.
, “Symptomatic Clusters Related to Amyloid Positivity in Cognitively Unimpaired Individuals.”, J Alzheimers Dis, vol. 100, no. 1, pp. 193-205, 2024.
, “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
, “A systematic review of lifestyle-based interventions for managing Alzheimer's disease: Insights from randomized controlled trials.”, J Alzheimers Dis, vol. 102, no. 4, pp. 943-966, 2024.
, “Transcriptomic Profiling Reveals Neuroinflammation in the Corpus Callosum of a Transgenic Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 97, no. 3, pp. 1421-1433, 2024.
, “Unveiling New Strategies Facilitating the Implementation of Artificial Intelligence in Neuroimaging for the Early Detection of Alzheimer's Disease.”, J Alzheimers Dis, vol. 99, no. 1, pp. 1-20, 2024.
, “Vaccines and Dementia: Part I. Non-Specific Immune Boosting with BCG: History, Ligands, and Receptors.”, J Alzheimers Dis, vol. 98, no. 2, pp. 343-360, 2024.
, “Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia.”, J Alzheimers Dis, vol. 98, no. 2, pp. 361-372, 2024.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Baseline associations of office and ambulatory blood pressure monitoring with cognitive function and dementia prevalence.”, J Alzheimers Dis, p. 13872877251322400, 2025.
, “Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting.”, J Alzheimers Dis, p. 13872877251323231, 2025.
, “Dynamic PET imaging in patients with unilateral carotid occlusion shows lateralized cerebral hypoperfusion, but no amyloid binding.”, J Alzheimers Dis, p. 13872877251329593, 2025.
, “Factors associated with a healthy diet and willingness to change dietary behavior in older adults at increased risk of dementia.”, J Alzheimers Dis, p. 13872877251330296, 2025.
, “Increased risk of dementia associated with herpes simplex virus infections: Evidence from a retrospective cohort study using U.S. electronic health records.”, J Alzheimers Dis, p. 13872877251317228, 2025.
, “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
, “Leptin, adiponectin, body mass index, and incident cognitive impairment.”, J Alzheimers Dis, p. 13872877251326060, 2025.
, “Lipopolysaccharides from indirectly induce neuronal GSK3β-dependent synaptic defects and cause cognitive decline in a low-amyloid-β-concentration environment in Alzheimer's disease.”, J Alzheimers Dis, p. 13872877251326879, 2025.
, “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
, “Medications and cognitive decline in Alzheimer's disease: Cohort cluster analysis of 15,428 patients.”, J Alzheimers Dis, p. 13872877241307870, 2025.
,